Lobo, Juliet G.

HRN: 20-89-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
CEFUROXIME 500MG (TAB)
04/06/2024
04/12/2024
PO
500mg
BID
NSVD Wbc Of 19
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: